浙江大學(xué)醫(yī)學(xué)院導(dǎo)師:朱麗君

發(fā)布時間:2021-10-07 編輯:考研派小莉 推薦訪問:
浙江大學(xué)醫(yī)學(xué)院導(dǎo)師:朱麗君

浙江大學(xué)醫(yī)學(xué)院導(dǎo)師:朱麗君內(nèi)容如下,更多考研資訊請關(guān)注我們網(wǎng)站的更新!敬請收藏本站,或下載我們的考研派APP和考研派微信公眾號(里面有非常多的免費(fèi)考研資源可以領(lǐng)取,有各種考研問題,也可直接加我們網(wǎng)站上的研究生學(xué)姐微信,全程免費(fèi)答疑,助各位考研一臂之力,爭取早日考上理想中的研究生院校。)

浙江大學(xué)醫(yī)學(xué)院導(dǎo)師:朱麗君 正文


  姓名:朱麗君
  性別:女
  所在學(xué)院:醫(yī)學(xué)院
  職稱:副教授

  研究方向:
  神經(jīng)生物學(xué),突觸傳遞的細(xì)胞和分子機(jī)制

  學(xué)歷和研究經(jīng)歷:
  畢業(yè)于浙江醫(yī)科大學(xué)生物醫(yī)學(xué)工程系,畢業(yè)后分配到浙江醫(yī)科大學(xué)分子生物學(xué)實(shí)驗(yàn)室工作,2002 年成立神經(jīng)生物學(xué)教研室后轉(zhuǎn)入神經(jīng)生物學(xué)教研室從事教學(xué)和科研工作,同年以同等學(xué)力考上博士研究生,2005年6月畢業(yè),獲博士學(xué)位。
  2003年3月至2005年4月公派赴美國City of Hope National Medical Center從事訪問學(xué)者研究工作,2006年11月至2007年2月赴香港科技大學(xué)生物化學(xué)系從事合作研究。
  主要研究方向?yàn)殡x子型谷氨酸受體及其亞單位在中樞神經(jīng)系統(tǒng)生理及病理過程中的作用。

  近幾年主要科研項(xiàng)目:
  1.神經(jīng)元信息感受重要蛋白質(zhì)膜轉(zhuǎn)運(yùn)的結(jié)構(gòu)基礎(chǔ)、調(diào)控及功能研究 國家重點(diǎn)基礎(chǔ)研究(973)2010CB912002, 2010.1-2014.12(學(xué)術(shù)骨干)
  2.PICK1蛋白磷酸化位點(diǎn)的鑒定和磷酸化功能研究,浙江省自然科學(xué)基金 Y2090195 2010.1 – 2011.12 (負(fù)責(zé)人)
  3.核糖核苷酸還原酶亞基特異性抗腫瘤藥物設(shè)計(jì)與生物活性研究。浙江省科技計(jì)劃項(xiàng)目,2008.1-2010.12(負(fù)責(zé)人)
  4.白細(xì)胞介素-2參與海馬突觸傳遞和可塑性調(diào)節(jié)及其機(jī)制的研究, 國家自然科學(xué)基金項(xiàng)目, J20060472, 2007.1-2009.12 (負(fù)責(zé)人,已結(jié)題)

  代表論文:
 ?。?) Lijun Zhu, Bingsen Zhou, Xinhuan Chen et al. Inhibitory mechanisms of heterocyclic carboxaldehyde thiosemicabazones for two forms of human ribonucleotide reductase. Biochemical Pharmacology 2009;78:1178-1185.
  (2) Shao Xin*, Lijun Zhu*, Yubin Wang et al. Threonine 82 at the PDZ Domain of PICK1 is Critical for AMPA Receptor Interaction and Localization, Neurochemistry International (accepted) (* co-first author)
 ?。?) Yi Shen, ShuangShuang Liu, MinYe Zhan, Jianhong Luo, Lijun Zhu. Interleukin-2 enhances dendritic development and spinogenesis in cultured hippocampal neurons. Anatomical Record (accepted) .
 ?。?) Yi Shen*, Li-Jun Zhu*, Shuang-Shuang Liu, Su-Ya Zhou and Jian-Hong Luo. Interleukin-2 inhibits NMDA receptor-mediated currents directly and may differentially affect subtypes. Biochem Biophys Res Commun. 2006 Dec 15;351(2):449-54. (* co-first author)
 ?。?) Min Guan, Lijun Zhu, George Somlo, et al. Bortezomib therapeutic effect is associated with expression of FGFR3 in multiple myeloma cells. Anticancer Res. 2009 Jan;29(1):1-9.
 ?。?) Lijun Zhu, George Somlo, Bingsen Zhou, et al. Fibroblast Growth Factor Receptor 3 inhibited by short-hairpin RNAs Leads to Apoptosis in Multiple Myeloma. Molecular Cancer Therapeutics 2005 May;4(5):787-98
 ?。?) Lijun Zhu, Yun Yen, Jimin Shao, et al.Fibroblast Growth Factor Receptor 3 Up-regulates Vascular Endothelial Growth Factor Expression In L6 Cells. International Journal of pharmacology 2(3): 324-330, 2006 .
 ?。?) Zhu Lijun, Chen Z, Zhang LS, Xu SJ, Xu AJ, Luo JH. Spatiotemporal changes of the N-methyl-D-aspartate receptor subunit levels in rats with pentylenetetrazole-induced seizures. Neurosci Lett. 2004 Feb 6;356(1):53-6.
  (9) Jimin Shao, Bingsen Zhou, Lijun Zhu, Weihua Qiu, Yate-Ching Yuan, Bixin Xi, and Yun Yen. In vitro characterization of enzymatic properties and inhibition of the p53R2 subunit of human ribonucleotide reductase. Cancer Research 2004; 64: 1-6.
 ?。?0) Jimin Shao, Bingsen Zhou, Lijun Zhu, Angel J. Di Bilio, Leila Su, Yate-Ching Yuan, Shijun Ren, Eric J. Lien, Jennifer Shih, and Yun Yen. Determination of the potency and subunit-selectivity of ribonucleotide reductase inhibitors with a recombinant-holoenzyme-based in vitro assay. Biochemical Pharmacology 2005; 69: 627–634.
 ?。?1) Shao J, Zhou B, Di Bilio AJ, Zhu Lijun, Wang T, Qi C, Shih J, Yen Y. A Ferrous-Triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase.Mol Cancer Ther. 2006 Mar;5(3):586-92.
 ?。?2) Chung V, Zhou B, Liu X, Zhu Lijun, Boo LM, Nguyen HV, Ann DK, Song J, Chen Y, Yen Y. SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone. Mol Cancer Ther. 2006 Mar;5(3):533-40.
  (13) Xu SJ, Chen Z, Zhu Lijun, Shen HQ, Luo JH. Visual recognition memory is related to basic expression level of NMDA receptor NR1/NR2B subtype in hippocampus and striatum of rats. Acta Pharmacol Sin. 2005 Feb;26(2):177-80.
 ?。?4) Chen zhong, Li Weidong, Zhu Lijun, Shen YingJie, Wei Erqing. Effects of histidine, a precursor of histamine, on pentylenetetrazole-induced seizures in rats Acta pharmacol Sin 2002;23(4) 361-366.
  國際會議論文:
  1. Lijun Zhu,Xin Shao, Huang WH, Wang YB, Yan XY, Zhu J, Shen Y, Xia J, Luo JH. Phosphorylation of PICK1 T82 is important for its interaction with GluR2 subunit of AMPA receptor and the receptor membrane trafficking. 2009 American society for neuroscience annual meeting, 2009/10/17-21.
  2. Lijun Zhu, George Somlo, Bingsen Zhou, Jimin Shao, Jennifer Shih, Jianhong Luo Yun Yen. shRNA-induced inhibition of Fibroblast Growth Factor Receptor 3 in t(4;14) translocated multiple myeloma cells. Porc Amer Assoc Cancer Res, volume 45,2004.
  3. Lijun Zhu, George Somlo, Bingsen Zhou, Jimin Shao, Kevin Clarke, Alison Hughes, Jianhong Luo, Yun Yen. Function of wild type fibroblast growth factor receptor 3 and Y373C, K650E mutants in human lymphoma U937 cells. Porc Amer Assoc Cancer Res, Volume 46,2005.
  4. Jimin Shao, Bingsen Zhou, Lijun Zhu et al., In vitro high throughput screening assay of novel inhibitors with reconstituted ribonucleotide reductase holoenzyme. Porc Amer Assoc Cancer Res, volume 45,2004.
  5. Min Guan, Lijun Zhu, George Somlo, Alison Hughes et al., Expression of wild type or specific mutations of FGFR3 in multiple myeloma cells is associated with variable PS-341 therapeutic effects. 98th AACR Annual Meeting—Apr 14-18, 2007; Los Angeles, CA
  6. Jimin Shao, Bingsen Zhou, Lijun Zhu et al., Characterization of the interacting mechanisms between triapine and the small subunits of human ribonucleotide reductase. Porc Amer Assoc Cancer Res, Volume 46,2005.
  7. JianHong Luo, Yu Gen, Lijun Zhu, D Ding Alternations in NMDA receptor subunit protein expression in different regions of rat brain following permanent ischemia Soc. Neurosci. Abstr. 1999;29:59 2
  榮譽(yù)和獎項(xiàng):
  NMDA受體亞單位組成及其在發(fā)育過程中的表達(dá) 獲1999年度衛(wèi)生部醫(yī)藥科技進(jìn)步三等獎(排名第4)
  參編教材:
  網(wǎng)絡(luò)生物信息數(shù)據(jù)庫及相關(guān)軟件的應(yīng)用。醫(yī)學(xué)分子細(xì)胞生物學(xué)--研究策略和技術(shù)原理。羅建紅主編。校內(nèi)研究生教材

以上老師的信息來源于學(xué)校網(wǎng)站,如有更新或錯誤,請聯(lián)系我們進(jìn)行更新或刪除,聯(lián)系方式

添加浙江大學(xué)學(xué)姐微信,或微信搜索公眾號“考研派小站”,關(guān)注[考研派小站]微信公眾號,在考研派小站微信號輸入[浙江大學(xué)考研分?jǐn)?shù)線、浙江大學(xué)報錄比、浙江大學(xué)考研群、浙江大學(xué)學(xué)姐微信、浙江大學(xué)考研真題、浙江大學(xué)專業(yè)目錄、浙江大學(xué)排名、浙江大學(xué)保研、浙江大學(xué)公眾號、浙江大學(xué)研究生招生)]即可在手機(jī)上查看相對應(yīng)浙江大學(xué)考研信息或資源

浙江大學(xué)考研公眾號 考研派小站公眾號
浙江大學(xué)

本文來源:http://alternativeofficeassistance.com/zhejiangdaxue/daoshi_481420.html

推薦閱讀